IGM Biosciences, Inc. Restricted Cash
IGM Biosciences, Inc. had Restricted Cash of $0 as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2025-07-31
- 2025-06-30: Restricted Cash $0.00.
- 2025-03-31: Restricted Cash $0.00.
- 2024-12-31: Restricted Cash $167.00K.
- 2024-09-30: Restricted Cash $190.00K.
| Period end | Restricted Cash |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $167.00K 10-Q · filed 2025-07-31 |
| 2024-09-30 | $190.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $289.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $325.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $592.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $617.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $642.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $658.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $689.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $693.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $697.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $698.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $701.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |